Publications by authors named "Thomas Olin"

Claim this Profile
A
A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).
Wen Zhong, Parviz Kokhaei, Tom A Mulder, Amineh Ghaderi, Ali Moshfegh, Thomas Olin

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractalkine Signalling (CXCL1/CXCR1 Axis) as an Emerging Target in Coronary Artery Disease.
Shu Xian Loh, Yasemin Ekinci, Luke Spray, Visvesh Jeyalan, Thomas Olin

J Clin Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.
Amineh Ghaderi, Mohammad-Ali Okhovat, Jemina Lehto, Luigi De Petris, Ehsan Manouchehri Doulabi, Thomas Olin

Pharmaceutics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells.
Amineh Ghaderi, Wen Zhong, Mohammad Ali Okhovat, Johanna Aschan, Ann Svensson, Thomas Olin

Pharmaceutics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
Mohammad Hojjat-Farsangi, Ali Moshfegh, Johan Schultz, Martin Norin, Thomas Olin

Handb Exp Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib-resistant ROR1 CLL cells.
Amineh Ghaderi, Mohammad-Ali Okhovat, Layung Sekar Sih Wikanthi, Ann Svensson, Marzia Palma, Thomas Olin

EJHaem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.
Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh, Parviz Kokhaei, Jan Vågberg, Thomas Olin

Biomedicines· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
Amir Hossein Daneshmanesh, Mohammad Hojjat-Farsangi, Amineh Ghaderi, Ali Moshfegh, Lotta Hansson, Thomas Olin

PLoS One· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination.
Nina M S Gustafsson, Katarina Färnegårdh, Nadilly Bonagas, Anna Huguet Ninou, Petra Groth, Thomas Olin

Nat Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis